Definitive Contract 75D30121C10052
Award Date 10/30/20
Potential Completion Date 3/5/22
Potential Value $48M
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Burlington, NC, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
4
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $91,693,500.00 firm-fixed-price definitive federal contract awarded by the Centers for Disease Control and Prevention (CDC) to Laboratory Corporation of America (Labcorp), a leading global life sciences company, for COVID-19 laboratory testing services. The contract has an ultimate completion date of April 22, 2025. Labcorp, a for-profit organization headquartered in Burlington, North Carolina, is the prime contractor and does not have any set-aside designation. The contract is not...
- The Centers for Disease Control and Prevention (CDC) awarded a $1.249 million firm fixed price delivery order contract to Laboratory Corporation of America Holdings (LabCorp) for surge serology testing. Under the contract, LabCorp will provide serology testing services to the CDC in Burlington, North Carolina through December 2020 to support the agency's COVID-19 response efforts. No subcontractors or set aside designations were identified. The CDC is a component of the U.S. Department of Health...
- This is a $1,974,948.75 definitive federal contract awarded by the Centers for Disease Control and Prevention (CDC) to Laboratory Corporation of America Holdings (LabCorp), a global life sciences company. The contract is for medical laboratory testing and analysis services, including clinical diagnostics, reference laboratory testing, genetic testing, and specialized medical analyses. The contract does not have a set-aside designation, indicating LabCorp competed in an open market procurement....
- Laboratory Corporation of America Holdings, doing business as Labcorp, has been awarded a definitive contract valued at $4.19 million by the Centers for Disease Control and Prevention to conduct an Assessment of SARS-CoV-2 Seroprevalence and Immune Responses. The contract is a firm fixed price agreement for Labcorp to perform seroprevalence studies and analyze immune responses to COVID-19 in Burlington, North Carolina over an eight-month period ending in February 2022. No subcontractors or set...
- The Centers for Disease Control and Prevention awarded a $2.8 million firm fixed price contract to Laboratory Corporation of America, operating as Labcorp, to provide residual blood specimen collection and SARS-CoV-2 serology testing services under the Multistate Assessment of SARS-CoV-2 Seroprevalence study. Labcorp will collect approximately 33,800 residual sera samples per month from all 50 states, Washington D.C. and Puerto Rico, distributed by age, and test for SARS-CoV-2 nucleocapsid...
- This is a $13,031,850.00 firm-fixed price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Laboratory Corporation of America (LabCorp) for genomic sequencing services. The contract has an ultimate completion date of May 14, 2022 and was awarded on December 26, 2021. LabCorp is a leading global life sciences company that provides diagnostic information services. They have extensive experience contracting with the federal government, including through their...
- Laboratory Corporation of America Holdings has been awarded a $533,990 firm fixed price delivery order by the Centers for Disease Control and Prevention in Pittsburgh for surge serology testing in support of coronavirus COVID-19 efforts. The contract runs from January 14, 2021 through April 26, 2021 and will see Laboratory Corporation perform serology testing services from its location in Burlington, North Carolina. No subcontractors or set aside designations were specified. This delivery...
- This is a firm fixed-price delivery order contract awarded to Laboratory Corporation of America (Labcorp) by the Centers for Disease Control and Prevention (CDC) on May 18, 2020. The contract is for "CLINIC LAB TESTS" and has a ceiling value of $90,043.40. The place of performance is in Burlington, North Carolina. This contract is not set aside for small businesses. Labcorp is a leading global life sciences company that provides comprehensive diagnostic testing and medical laboratory...
- The U.S. Department of the Army Medical Command awarded a firm fixed price delivery order contract for $300,074.75 to Laboratory Corporation of America (LabCorp), a leading global life sciences company, for clinical reference laboratory testing services. This contract was not set aside and does not appear to be part of a larger contracting vehicle. LabCorp has been awarded numerous federal contracts to provide medical laboratory testing and analysis services in support of government healthcare...
- Laboratory Corporation of America (LabCorp) has been awarded a firm fixed price purchase order by the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh. The contract value is $27.94 million to provide SARS-COV-2 SPHERES BASELINE GENOMIC SEQUENCING. No set aside designation was specified. As the prime contractor, LabCorp will deliver genomic sequencing services in support of the CDC's efforts to track variations in the SARS-COV-2 virus. LabCorp operates...